Ratings Moves: ING,...
Health Care: Drugs
Galena Biopharma Inc (GALE: NASDAQ)
$2.57 -0.03 | -1.06%
05/24/13 - 02:10 PM ET
550.38K / 2.03M
Vol / Avg. Vol:2.61 / 2.60
Open / Prev. Close:2.52 - 2.61
Today's Range:1.17 - 3.00
52 Wk Range:68.63%
Performance YTD:TheStreet Rating:
Portfolios with GALE
- Portfolio NameUser Type
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Moving Hig...
- UserMy Portfolio
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Setting Up...
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Moving Hig...
Latest GALE Headlines from TheStreet
- Galena Biopharma To Present At The 2013 Marcum MicroCap Conference 05.23.13 | 07:05 am
- VIDEO RELEASE -- Galena Biopharma Reports First Quarter 2013 Financial Results 05.09.13 | 04:05 pm
- Galena Biopharma Poster Presentation At The American Pain Society 32nd Annual Scientific Meeting 05.09.13 | 07:05 am
- William L. Ashton Joins Galena Biopharma's Board Of Directors 05.01.13 | 07:05 am
- Galena Biopharma To Present At The 12th Annual Needham Healthcare Conference 04.24.13 | 07:04 am
- Galena Biopharma To Present At The 2013 BIO International Convention 04.16.13 | 07:04 am
- Biotech Stock Mailbag: Exact Sciences, Galena, Titan, Arena, Breakthrough Therapy 04.12.13 | 06:04 am
- 4 Biotech Stocks Under $10 Making Big Moves 04.09.13 | 02:04 pm
- Galena Biopharma To Present At The 20th Annual Future Leaders In The Biotech Industry Conference 03.29.13 | 07:03 am
- 4 Stocks Under $10 Making Big Moves 03.26.13 | 02:03 pm
Press Releases for GALE
- Frost & Sullivan Applauds Galena Biopharma For Its Breakthrough Breast Cancer Vaccine, NeuVaxâ¿¢ - PR Newswire 03.12.13 | 07:03 am
- Galena Biopharma, Inc. Investor Presentation Now Available For On-demand Viewing At RetailInvestorConferences.com - PR Newswire 06.12.12 | 09:06 am
- Galena Biopharma, Inc. To Webcast, Live, At RetailInvestorConferences.com On June 7th - PR Newswire 06.06.12 | 09:06 am
- RXi Pharmaceuticals’ Common Stock To Commence Trading Under The Symbol “RXII” - Business Wire 05.10.12 | 06:05 am
Partner Headlines for GALE
- Galena Biopharma: Will Developments Continue In 2013? - Seeking Alpha 04.03.13 | 09:04 am
- What Makes For A Market Leading Return In Biotechnology? - Seeking Alpha 01.22.13 | 09:01 am
- Galena Pulls Back While Analysts Rush To Its Defense - Seeking Alpha 12.17.12 | 08:12 am
- Biotech Under The Electron Microscope: What's In The Pipeline And Lessons To Be Learned - Seeking Alpha 12.16.12 | 08:12 am
- Morning Market Movers - Benzinga 12.04.12 | 09:12 am
- UPDATE: Aegis Capital Corp. Initiates Coverage on Galena Biopharma with Buy Rating, $6 PT - Benzinga 11.28.12 | 09:11 am
- A Gold Mine In Biotechnology: The Companies Poised To Benefit - Seeking Alpha 09.04.12 | 09:09 am
- Reassessing & Continuing To Monitor Portfolios For Success - Seeking Alpha 07.30.12 | 09:07 am
- Are Galena Biopharma's Largest Shareholders Giddy About Their Drug Trial Results? - Wall St. Cheat Sheet 06.21.12 | 11:06 am
- Galena Biopharma Announces Public Offering of Common Stock - Benzinga 04.04.12 | 04:04 pm
